# BERRY- a Study of Sambucol ® in the Treatment, and Reduction of Symptoms in Participants With Coronavirus 19

> **NCT05489770** · NA · COMPLETED · sponsor: **East Kent Hospitals University NHS Foundation Trust** · enrollment: 204 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DIETARY_SUPPLEMENT:** Sambucol® Black Elderberry Original (Sambucus nigra) Liquid
- **DIETARY_SUPPLEMENT:** Placebo for Sambucol® Black Elderberry Original (Sambucus nigra)

## Key facts

- **NCT ID:** NCT05489770
- **Lead sponsor:** East Kent Hospitals University NHS Foundation Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-05
- **Primary completion:** 2022-05-16
- **Final completion:** 2022-05-16
- **Target enrollment:** 204 (ACTUAL)
- **Last updated:** 2024-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05489770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05489770, "BERRY- a Study of Sambucol ® in the Treatment, and Reduction of Symptoms in Participants With Coronavirus 19". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05489770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*